336 related articles for article (PubMed ID: 15828996)
1. Anesthesia in a child with homozygous porphobilinogen deaminase deficiency: a severe form of acute intermittent porphyria.
Sheppard L; Dorman T
Paediatr Anaesth; 2005 May; 15(5):426-8. PubMed ID: 15828996
[TBL] [Abstract][Full Text] [Related]
2. The use of rocuronium and sevoflurane in acute intermittent porphyria--a case report.
Hsieh CH; Hung PC; Chien CT; Shih YR; Peng SK; Luk HN; Tsai TC
Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):169-71. PubMed ID: 17037005
[TBL] [Abstract][Full Text] [Related]
3. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
Ulbrichova D; Hrdinka M; Saudek V; Martasek P
FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in a family with non-erythroid variant form of acute intermittent porphyria.
Yu S; Poulos V; Stewart P
J Hum Genet; 2000; 45(6):367-9. PubMed ID: 11185747
[TBL] [Abstract][Full Text] [Related]
5. Circulating fluorocytes at the first attack of acute intermittent porphyria: a missing link in the pathogenesis.
Lam CW; Lau KC; Mak CM; Tsang MW; Chan YW
Clin Chim Acta; 2011 Jan; 412(1-2):208-12. PubMed ID: 20850424
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene.
Astrin KH; Desnick RJ
Hum Mutat; 1994; 4(4):243-52. PubMed ID: 7866402
[TBL] [Abstract][Full Text] [Related]
7. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
[TBL] [Abstract][Full Text] [Related]
8. An odd case of heteroallelic acute intermittent porphyria in the Argentinean population.
Piñeiro Pauwels MB; Gerez EN; Martinez MC; Melito VA; Parera VE; Batlle A; Rossetti MV
Cell Mol Biol (Noisy-le-grand); 2013 Mar; 59 Suppl():OL1855-60. PubMed ID: 23522335
[TBL] [Abstract][Full Text] [Related]
9. Familial occurrence of myoclonic epilepsy syndrome and acute intermittent porphyria.
Varsik P; Buranová D; Kollár B; Traubner P; Bozek P; Mikulecký M
Neuro Endocrinol Lett; 2005 Feb; 26(1):7-12. PubMed ID: 15726012
[TBL] [Abstract][Full Text] [Related]
10. Identification of acute intermittent porphyria carriers by molecular biologic methods.
Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
[TBL] [Abstract][Full Text] [Related]
11. Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria.
Johansson A; Nowak G; Möller C; Harper P
Mol Genet Metab; 2004 May; 82(1):20-6. PubMed ID: 15110317
[TBL] [Abstract][Full Text] [Related]
12. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting.
Nunn AV; Gardner LC; Cox TM
Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663
[TBL] [Abstract][Full Text] [Related]
13. [Three new mutations in the porphobilinogen deaminase gene, detected in acute intermittent porphyria patients from Russia].
Surin VL; Luk'ianenko AV; Karpova IV; Misiurin AV; Pustovot IaS; Pivnik AV
Genetika; 2001 May; 37(5):690-7. PubMed ID: 11436563
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.
von Brasch L; Zang C; Haverkamp T; Schlechte H; Heckers H; Petrides PE
Blood Cells Mol Dis; 2004; 32(2):309-14. PubMed ID: 15003823
[TBL] [Abstract][Full Text] [Related]
15. Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria.
Guillén-Navarro E; Carbonell P; Glover G; Sánchez-Solís M; Fernández-Barreiro A
Ann Hum Genet; 2004 Sep; 68(Pt 5):509-14. PubMed ID: 15469427
[TBL] [Abstract][Full Text] [Related]
16. Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs.
Ruspini SF; Zuccoli JR; Lavandera JV; Martínez MDC; Oliveri LM; Gerez EN; Batlle AMDC; Buzaleh AM
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1296-1305. PubMed ID: 29476795
[TBL] [Abstract][Full Text] [Related]
17. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
Lindberg RL; Porcher C; Grandchamp B; Ledermann B; Bürki K; Brandner S; Aguzzi A; Meyer UA
Nat Genet; 1996 Feb; 12(2):195-9. PubMed ID: 8563760
[TBL] [Abstract][Full Text] [Related]
18. Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.
Hessels J; Voortman G; van der Wagen A; van der Elzen C; Scheffer H; Zuijderhoudt FM
J Inherit Metab Dis; 2004; 27(1):19-27. PubMed ID: 14970743
[TBL] [Abstract][Full Text] [Related]
19. Acute intermittent porphyria presenting with a subarachnoid haemorrhage.
van Heyningen C; Simms DM
Ann Clin Biochem; 2008 Nov; 45(Pt 6):610-1. PubMed ID: 18782811
[TBL] [Abstract][Full Text] [Related]
20. Acute intermittent porphyria: laboratory diagnosis by molecular methods.
Schreiber WE
Clin Lab Med; 1995 Dec; 15(4):943-56. PubMed ID: 8838232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
